$KITE Kite Pharma, Inc. Insider Trading Week 25/2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Kite Pharma, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Kite Pharma, Inc. in week 25/2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 22 2017 | KITE | Kite Pharma, Inc. | CHAMPSI FARAH | Director | Option Exercise | A | 91.21 | 8,810 | 803,560 | 8,810 | |
| Jun 22 2017 | KITE | Kite Pharma, Inc. | CHAMPSI FARAH | Director | Grant | A | 0.00 | 2,410 | 0 | 66,074 | 63.7 K to 66.1 K (+3.79 %) |
| Jun 22 2017 | KITE | Kite Pharma, Inc. | BONDERMAN DAVID | Director | Option Exercise | A | 91.21 | 8,810 | 803,560 | 8,810 | |
| Jun 22 2017 | KITE | Kite Pharma, Inc. | BONDERMAN DAVID | Director | Grant | A | 0.00 | 2,410 | 0 | 4,360 | 2 K to 4.4 K (+123.59 %) |
| Jun 22 2017 | KITE | Kite Pharma, Inc. | CLARK IAN T | Director | Option Exercise | A | 91.21 | 8,810 | 803,560 | 8,810 | |
| Jun 22 2017 | KITE | Kite Pharma, Inc. | CLARK IAN T | Director | Grant | A | 0.00 | 2,410 | 0 | 7,100 | 4.7 K to 7.1 K (+51.39 %) |
| Jun 22 2017 | KITE | Kite Pharma, Inc. | DOUMANI ROY | Director | Option Exercise | A | 91.21 | 8,810 | 803,560 | 8,810 | |
| Jun 22 2017 | KITE | Kite Pharma, Inc. | DOUMANI ROY | Director | Grant | A | 0.00 | 2,410 | 0 | 152,427 | 150 K to 152.4 K (+1.61 %) |
| Jun 22 2017 | KITE | Kite Pharma, Inc. | Humer Franz B | Director | Option Exercise | A | 91.21 | 8,810 | 803,560 | 8,810 | |
| Jun 22 2017 | KITE | Kite Pharma, Inc. | Humer Franz B | Director | Grant | A | 0.00 | 2,410 | 0 | 6,431 | 4 K to 6.4 K (+59.94 %) |
| Jun 22 2017 | KITE | Kite Pharma, Inc. | Kazam Joshua A | Director | Option Exercise | A | 91.21 | 8,810 | 803,560 | 8,810 | |
| Jun 22 2017 | KITE | Kite Pharma, Inc. | Kazam Joshua A | Director | Grant | A | 0.00 | 2,410 | 0 | 4,360 | 2 K to 4.4 K (+123.59 %) |
| Jun 22 2017 | KITE | Kite Pharma, Inc. | Nussbaum Ran | Director | Option Exercise | A | 91.21 | 8,810 | 803,560 | 8,810 | |
| Jun 22 2017 | KITE | Kite Pharma, Inc. | Nussbaum Ran | Director | Grant | A | 0.00 | 2,410 | 0 | 4,360 | 2 K to 4.4 K (+123.59 %) |
| Jun 22 2017 | KITE | Kite Pharma, Inc. | Ruchefsky Steven B | Director | Option Exercise | A | 91.21 | 8,810 | 803,560 | 8,810 | |
| Jun 22 2017 | KITE | Kite Pharma, Inc. | Ruchefsky Steven B | Director | Grant | A | 0.00 | 2,410 | 0 | 207,836 | 205.4 K to 207.8 K (+1.17 %) |
| Jun 22 2017 | KITE | Kite Pharma, Inc. | Peacock Jonathan M | Director | Option Exercise | A | 91.21 | 8,810 | 803,560 | 8,810 | |
| Jun 22 2017 | KITE | Kite Pharma, Inc. | Peacock Jonathan M | Director | Grant | A | 0.00 | 2,410 | 0 | 70,374 | 68 K to 70.4 K (+3.55 %) |
| Jun 22 2017 | KITE | Kite Pharma, Inc. | WITTE OWEN N. | Director | Option Exercise | A | 91.21 | 8,810 | 803,560 | 8,810 | |
| Jun 22 2017 | KITE | Kite Pharma, Inc. | WITTE OWEN N. | Director | Grant | A | 0.00 | 2,410 | 0 | 88,750 | 86.3 K to 88.8 K (+2.79 %) |